Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0000899243-18-007825

Chief Executive Officer sold 100,000 shares at $24.75 ($2,475,000)

  • Chief Executive Officer acquired 100,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Quart Barry D · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-03-14 Exercise or conversion : show line 1 in the form +100,000 $7.20 $720,000 167,993 D
2018-03-14 Sale : show line 2 in the form −100,000 $24.75 $2,475,000 67,993 D
Open-market sales · 100,000 sh · avg $24.75 · $2,475,000

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-03-14 Exercise or conversion : show line 3 in the form Employee Stock Option(Right to Buy) −100,000 $7.20 2023-05-01 100,000 830,276 D
Loading xslF345X03/doc4.xml…